Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / FundiShares S&P 500 EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCF(EUR) F
ETF TickerIUES.AS(EUR) CXE
ETF TickerIUSE.L(EUR) CXE
ETF TickerIUSE.MI(EUR) CXE
ETF TickerIUSEz(EUR) CXE
ETF TickerIUSE(EUR) ETF Plus

Holdings detail for SOLV

Stock NameSolventum Corp.
TickerSOLV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS83444M1018

Show aggregate SOLV holdings

News associated with SOLV

Wells Fargo & Company Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price
Solventum (NYSE:SOLV – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from $79.00 to $82.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-09-17 03:06:58
Solventum Completes Sale Of Purification & Filtration Business; Raises Annual Earnings Outlook
(RTTNews) - Solventum Corporation (SOLV) Tuesday said that it has completed the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. (TMO) for $4 billion in cash. - 2025-09-02 10:10:37
Solventum (NYSE:SOLV) Rating Increased to Strong-Buy at Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other equities research analysts have also issued reports on SOLV. KeyCorp started coverage on Solventum in a report on Friday, June 6th. They set a […] - 2025-09-01 03:10:44
Solventum (NYSE:SOLV) Stock Rating Lowered by Wall Street Zen
Solventum (NYSE:SOLV – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. A number of other brokerages have also recently commented on SOLV. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to […] - 2025-08-24 06:14:43
Solventum Corporation (NYSE:SOLV) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lessened its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 18.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,479 shares of the company’s stock after selling 1,439 shares during the quarter. Maryland State Retirement […] - 2025-08-15 04:51:01
Solventum Announces Pricing Of Secondary Offering Of 8.80 Mln Common Stock
(RTTNews) - Solventum Corp. (SOLV) announced the pricing of the secondary offering of 8.80 million shares of its common stock, which is expected to result in gross proceeds of about $648 million to 3M Company. All of the shares of common stock are being sold by the Selling Shareh - 2025-08-14 00:33:56
Solventum Corporation (NYSE:SOLV) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,173,960 shares of the company’s stock after buying an additional 24,762 shares during the quarter. Charles Schwab Investment Management […] - 2025-08-13 05:10:47
Blair William & Co. IL Sells 552 Shares of Solventum Corporation (NYSE:SOLV)
Blair William & Co. IL lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 4.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,010 shares of the company’s stock after selling 552 shares during the period. Blair William & Co. IL’s holdings in Solventum were worth $837,000 at […] - 2025-08-11 06:24:58
Federated Hermes Inc. Trims Position in Solventum Corporation (NYSE:SOLV)
Federated Hermes Inc. trimmed its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 67.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 764 shares of the company’s stock after selling 1,595 shares during the quarter. Federated Hermes Inc.’s holdings in Solventum were worth $58,000 as of its most recent filing with […] - 2025-08-11 05:04:58
Solventum (NYSE:SOLV) Price Target Raised to $94.00
Solventum (NYSE:SOLV – Free Report) had its price objective upped by Piper Sandler from $87.00 to $94.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the company. Morgan Stanley raised Solventum from […] - 2025-08-11 03:08:46
XTX Topco Ltd Grows Stock Position in Solventum Corporation (NYSE:SOLV)
XTX Topco Ltd lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 26.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,417 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-08 04:38:55
Noteworthy Thursday Option Activity: AKAM, EXPE, SOLV
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Akamai Technologies Inc (Symbol: AKAM), where a total of 8,566 contracts have traded so far, representing approximately 856,600 underlying shares. That amounts to about 5 - 2025-08-07 14:17:28
Financial Analysis: Solventum (NYSE:SOLV) and BG Medicine (OTCMKTS:BGMD)
BG Medicine (OTCMKTS:BGMD – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares BG Medicine and […] - 2025-08-05 02:41:00
Solventum Corporation (NYSE:SOLV) Receives $84.38 Average Target Price from Brokerages
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-08-01 02:50:51
Universal Beteiligungs und Servicegesellschaft mbH Buys 584 Shares of Solventum Corporation (NYSE:SOLV)
Universal Beteiligungs und Servicegesellschaft mbH increased its stake in Solventum Corporation (NYSE:SOLV – Free Report) by 1.1% during the 1st quarter, Holdings Channel reports. The firm owned 53,143 shares of the company’s stock after purchasing an additional 584 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Solventum were worth $4,041,000 at the […] - 2025-07-29 05:22:58
7,059 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,059 shares of the company’s stock, valued at approximately $537,000. Several other institutional investors have also added to or reduced their stakes […] - 2025-07-28 06:02:51
New York State Common Retirement Fund Reduces Holdings in Solventum Corporation (NYSE:SOLV)
New York State Common Retirement Fund lowered its position in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 24.1% during the first quarter, Holdings Channel reports. The fund owned 67,549 shares of the company’s stock after selling 21,500 shares during the quarter. New York State Common Retirement Fund’s holdings in Solventum were worth $5,136,000 […] - 2025-07-22 07:09:10
Solventum Corporation (NYSE:SOLV) Shares Sold by Cwm LLC
Cwm LLC cut its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,875 shares of the company’s stock after selling 2,420 shares during the period. Cwm LLC’s holdings in Solventum […] - 2025-07-21 05:18:49
Cerity Partners LLC Buys 1,294 Shares of Solventum Corporation (NYSE:SOLV)
Cerity Partners LLC grew its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 2.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,466 shares of the company’s stock after buying an additional 1,294 shares during the quarter. Cerity Partners […] - 2025-07-18 04:55:04
Solventum Corporation (NYSE:SOLV) Shares Sold by Arizona State Retirement System
Arizona State Retirement System trimmed its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 0.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,466 shares of the company’s stock after selling 173 shares during the period. Arizona […] - 2025-07-17 05:51:11
Morgan Stanley Upgrades Solventum (NYSE:SOLV) to Overweight
Solventum (NYSE:SOLV – Get Free Report) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Tuesday, Marketbeat.com reports. The brokerage presently has a $103.00 target price on the stock, up from their prior target price of $80.00. Morgan Stanley’s price target […] - 2025-07-17 05:00:52
Solventum Corporation (NYSE:SOLV) Shares Sold by Stratos Wealth Partners LTD.
Stratos Wealth Partners LTD. lessened its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 50.6% in the 1st quarter, Holdings Channel reports. The firm owned 4,256 shares of the company’s stock after selling 4,355 shares during the period. Stratos Wealth Partners LTD.’s holdings in Solventum were worth $324,000 at the end of […] - 2025-07-16 04:58:53
Solventum Corporation (NYSE:SOLV) Shares Sold by D.A. Davidson & CO.
D.A. Davidson & CO. lowered its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 11.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,478 shares of the company’s stock after selling 1,002 shares during the period. D.A. Davidson & CO.’s holdings in Solventum were worth […] - 2025-07-11 05:26:54
Solventum Corporation (NYSE:SOLV) Receives $81.50 Average Price Target from Analysts
Shares of Solventum Corporation (NYSE:SOLV – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to […] - 2025-07-07 02:06:56
Solventum Corporation (NYSE:SOLV) Position Lessened by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 4.5% during the 1st quarter, HoldingsChannel reports. The firm owned 18,893 shares of the company’s stock after selling 895 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Solventum were worth $1,437,000 as of its most recent […] - 2025-07-04 04:32:51
Sumitomo Mitsui Trust Group Inc. Sells 586 Shares of Solventum Corporation (NYSE:SOLV)
Sumitomo Mitsui Trust Group Inc. reduced its holdings in Solventum Corporation (NYSE:SOLV – Free Report) by 0.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 319,689 shares of the company’s stock after selling 586 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Solventum were worth $24,309,000 at the end of […] - 2025-07-03 05:35:09
Robeco Institutional Asset Management B.V. Purchases 2,544 Shares of Solventum Corporation (NYSE:SOLV)
Robeco Institutional Asset Management B.V. lifted its position in Solventum Corporation (NYSE:SOLV – Free Report) by 8.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 31,238 shares of the company’s stock after purchasing an additional 2,544 shares during the quarter. Robeco Institutional Asset Management […] - 2025-07-02 06:14:53
Mirae Asset Global Investments Co. Ltd. Decreases Position in Solventum Corporation (NYSE:SOLV)
Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,617 shares of the company’s stock after selling 3,174 shares […] - 2025-07-02 05:35:01
Perigon Wealth Management LLC Acquires 159 Shares of Solventum Corporation (NYSE:SOLV)
Perigon Wealth Management LLC raised its holdings in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 3.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,352 shares of the company’s stock after acquiring an additional 159 shares during the quarter. Perigon Wealth […] - 2025-07-01 05:09:18
Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC
Sequoia Financial Advisors LLC increased its stake in shares of Solventum Corporation (NYSE:SOLV – Free Report) by 137.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,344 shares of the company’s stock after purchasing an additional 10,027 shares during the quarter. […] - 2025-06-30 06:10:48

iShares S&P 500 EUR Hedged UCITS ETF (Acc) SOLV holdings

DateNumber of SOLV Shares HeldBase Market Value of SOLV SharesLocal Market Value of SOLV SharesChange in SOLV Shares HeldChange in SOLV Base ValueCurrent Price per SOLV Share HeldPrevious Price per SOLV Share Held
2025-09-18 (Thursday)26,916USD 1,699,850SOLV holding increased by 17430USD 1,699,8500USD 17,430 USD 63.1539 USD 62.5063
2025-09-17 (Wednesday)26,916USD 1,682,420SOLV holding decreased by -1079USD 1,682,4200USD -1,079 USD 62.5063 USD 62.5464
2025-09-16 (Tuesday)26,916SOLV holding increased by 40USD 1,683,499SOLV holding increased by 10092USD 1,683,49940USD 10,092 USD 62.5464 USD 62.264
2025-09-15 (Monday)26,876USD 1,673,407USD 1,673,407
2025-09-12 (Friday)26,836USD 1,679,453USD 1,679,453
2025-09-11 (Thursday)26,836USD 1,688,462SOLV holding increased by 58737USD 1,688,4620USD 58,737 USD 62.9178 USD 60.7291
2025-09-10 (Wednesday)26,836USD 1,629,725USD 1,629,725
2025-09-09 (Tuesday)26,756USD 1,662,628USD 1,662,628
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SOLV by Blackrock for IE00B3ZW0K18

Show aggregate share trades of SOLV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-16BUY40 62.546* 66.05
2025-08-21BUY31 61.981* 66.11
2025-08-20SELL-62 62.463* 66.13 Profit of 4,100 on sale
2025-08-13BUY62 63.467* 66.16
2025-08-12BUY31 61.835* 66.18
2025-08-08SELL-31 62.963* 66.23 Profit of 2,053 on sale
2025-08-05BUY62 62.623* 66.27
2025-08-04SELL-124 63.315* 66.28 Profit of 8,219 on sale
2025-08-01SELL-31 62.080* 66.31 Profit of 2,056 on sale
2025-07-31BUY93 62.348* 66.33
2025-07-30BUY31 63.571* 66.35
2025-07-18SELL-93 62.915* 66.47 Profit of 6,182 on sale
2025-07-16SELL-62 62.976* 66.51 Profit of 4,124 on sale
2025-07-10BUY31 64.963* 66.58
2025-07-07BUY62 64.949* 66.62
2025-07-02BUY31 66.497* 66.62
2025-06-24BUY62 64.543* 66.69
2025-06-23BUY31 63.527* 66.71
2025-06-18BUY31 63.110* 66.78
2025-06-17BUY31 63.121* 66.80
2025-06-05SELL-62 65.782* 66.90 Profit of 4,148 on sale
2025-06-03BUY62 65.183* 66.92
2025-05-28BUY341 64.263* 67.01
2025-05-27BUY93 63.951* 67.03
2025-05-22SELL-31 64.424* 67.13 Profit of 2,081 on sale
2025-05-21SELL-31 64.157* 67.15 Profit of 2,082 on sale
2025-05-20SELL-62 66.291* 67.16 Profit of 4,164 on sale
2025-05-19SELL-62 67.330* 67.15 Profit of 4,164 on sale
2025-05-15BUY31 65.201* 67.18
2025-05-14BUY62 63.441* 67.21
2025-05-13BUY93 65.863* 67.22
2025-05-12BUY186 67.315* 67.22
2025-05-09BUY93 62.324* 67.26
2025-05-02BUY31 59.478* 67.64
2025-04-28BUY31 58.063* 67.98
2025-04-25SELL-31 58.117* 68.07 Profit of 2,110 on sale
2025-04-24BUY93 59.375* 68.16
2025-04-23BUY31 58.062* 68.25
2025-04-22BUY31 56.578* 68.36
2025-04-16SELL-31 57.694* 68.78 Profit of 2,132 on sale
2025-04-15BUY31 58.201* 68.89
2025-04-14BUY62 59.644* 68.98
2025-04-11BUY62 58.376* 69.09
2025-04-10BUY31 58.289* 69.20
2025-04-09BUY31 62.128* 69.27
2025-04-08BUY62 57.749* 69.39
2025-04-07SELL-31 59.803* 69.49 Profit of 2,154 on sale
2025-04-04SELL-186 60.245* 69.59 Profit of 12,944 on sale
2025-04-01SELL-62 70.617* 69.57 Profit of 4,313 on sale
2025-03-31SELL-62 70.394* 69.56 Profit of 4,313 on sale
2025-03-28SELL-62 69.066* 69.57 Profit of 4,313 on sale
2025-03-25BUY31 69.376* 69.57
2025-03-21SELL-124 68.434* 69.60 Profit of 8,630 on sale
2025-03-20SELL-93 69.134* 69.60 Profit of 6,473 on sale
2025-03-18BUY186 68.912* 69.60
2025-03-11SELL-31 69.452* 69.70 Profit of 2,161 on sale
2025-03-10SELL-93 71.640* 69.67 Profit of 6,479 on sale
2025-03-07SELL-217 71.693* 69.64 Profit of 15,113 on sale
2025-03-05SELL-93 72.306* 69.61 Profit of 6,474 on sale
2025-03-03SELL-124 76.448* 69.44 Profit of 8,610 on sale
2025-02-27SELL-31 80.131* 69.18 Profit of 2,145 on sale
2025-02-19BUY31 70.971* 68.72
2025-02-18BUY62 71.023* 68.69
2025-02-13BUY62 71.223* 68.58
2025-02-05SELL-248 71.765* 68.25 Profit of 16,926 on sale
2025-02-04BUY31 71.875* 68.18
2025-01-29BUY31 71.497* 67.90
2025-01-28BUY31 71.831* 67.82
2025-01-24BUY93 71.297* 67.67
2025-01-23BUY217 70.786* 67.60
2025-01-22BUY155 70.694* 67.53
2025-01-21BUY31 71.170* 67.44
2025-01-16BUY186 70.569* 67.18
2025-01-15BUY31 69.895* 67.11
2025-01-10BUY31 65.437* 67.13
2024-12-10BUY31 66.372* 67.16
2024-12-09BUY124 66.682* 67.18
2024-12-05SELL-62 65.797* 67.26 Profit of 4,170 on sale
2024-12-04BUY93 66.727* 67.27
2024-12-03SELL-155 67.288* 67.27 Profit of 10,427 on sale
2024-12-02BUY62 68.762* 67.22
2024-11-25BUY62 68.275* 66.98
2024-11-22SELL-31 68.021* 66.93 Profit of 2,075 on sale
2024-11-21SELL-31 66.245* 66.96 Profit of 2,076 on sale
2024-11-18BUY155 63.479* 67.49
2024-11-12BUY31 66.638* 67.55
2024-11-08BUY210 67.383* 67.58
2024-11-07BUY60 69.432* 67.44
2024-11-06BUY30 69.041* 67.31
2024-10-31BUY93 66.854* 67.59
2024-10-29BUY31 67.926* 67.52
2024-10-28BUY31 67.810* 67.46
2024-10-25BUY31 67.571* 67.43
2024-10-24BUY31 67.794* 67.31
2024-10-23SELL-62 67.285* 67.32 Profit of 4,174 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SOLV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19179,6991247,01572.7%
2025-09-18190,93029298,08864.1%
2025-09-17498,6723687,70572.5%
2025-09-16228,165327380,92959.9%
2025-09-15554,89912778,87471.2%
2025-09-12588,13632828,29371.0%
2025-09-11246,9841766,54132.2%
2025-09-10188,827332335,56456.3%
2025-09-09188,522332341,42855.2%
2025-09-08365,458198631,15357.9%
2025-09-05127,61129238,25053.6%
2025-09-04156,465248253,84361.6%
2025-09-03159,378103300,28253.1%
2025-09-02159,60986281,26256.7%
2025-08-29113,32429255,67244.3%
2025-08-28190,310320342,93655.5%
2025-08-27156,02590316,14649.4%
2025-08-26123,604121173,81171.1%
2025-08-25156,1157260,24160.0%
2025-08-22240,180367380,07963.2%
2025-08-21140,496278208,89267.3%
2025-08-20154,256530300,20351.4%
2025-08-19141,00824317,43144.4%
2025-08-18272,5350526,91751.7%
2025-08-15397,918956744,78953.4%
2025-08-14785,818571,905,07941.2%
2025-08-13139,646264281,31249.6%
2025-08-1275,373138215,21035.0%
2025-08-11132,362550245,32754.0%
2025-08-08354,273107703,52250.4%
2025-08-07343,61845670,94451.2%
2025-08-06174,8056282,65761.8%
2025-08-05167,8260258,80264.8%
2025-08-04184,021466312,37558.9%
2025-08-01157,693108263,71559.8%
2025-07-31101,7588215,51047.2%
2025-07-3082,277230159,10351.7%
2025-07-2954,40929136,96039.7%
2025-07-2875,6080149,49950.6%
2025-07-2586,7330172,97050.1%
2025-07-2480,110112147,49954.3%
2025-07-2371,97091163,99143.9%
2025-07-2287,106348175,00649.8%
2025-07-2168,91526139,86949.3%
2025-07-1874,959145166,55545.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.